Hip Fracture In Early Stages of Type 2 Diabetes: A Population-Based Cohort Study by Prieto-Alhambra, D, Martinez-Laguna, D, Tebe, C, Nogues, X, Diez-Perez, A

The association between type 2 diabetes mellitus, hip fracture, and post-hip-fracture mortality: a multi-state cohort analysis by Tebe, C, Carbonell, C, Martinez-Laguna, D, Reyes-Reyes, C, Prieto-Alhambra, D

Predictors of post-operative mortality following total hip arthroplasty surgery: a population-based cohort study by Prieto-Alhambra, D, Tebe, C, Palliso, F, Judge, A, Arden, N, Cooper, C, Espallargues, M

2-year persistence with different anti-osteoporosis medications: a population-based cohort by Reyes, C, Tebe, C, Martinez-Laguna, D, Soria-Castro, A, Carbonell-Abella, C, Prieto-Alhambra, D

One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study. by Reyes, C, Tebe, C, Martinez-Laguna, D, Ali, M, Soria-Castro, A, Carbonell, C, Prieto-Alhambra, D

1 and 2-year persistence with different anti-osteoporosis medications per previous use and setting of therapy initiation: A population-based cohort study by Reyes, C, Tebe, C, Martinez-Laguna, D, Ali, M, Soria-Castro, A, Carbonell, C, Prieto-Alhambra, D

Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study. by Martinez-Laguna, D, Tebe, C, Javaid, M, Nogues, X, Arden, N, Cooper, C, Diez-Perez, A, Prieto-Alhambra, D

The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis by Tebé, C, Martínez-Laguna, D, Carbonell-Abella, C, Reyes, C, Moreno, V, Diez-Perez, A, Collins, G, Prieto Alhambra, D

The natural history of symptomatic COVID-19 during the first wave in Catalonia by Burn, E, Tebé, C, Fernandez-Bertolin, S, Aragon, M, Recalde, M, Roel, E, Prats-Uribe, A, Prieto Alhambra, D, Duarte-Salles, T

Fracture risk in type 2 diabetic patients: a clinical prediction tool based on a large population-based cohort by Martínez-Laguna, D, Tebe, C, Nogues, X, Javaid, M, Cooper, C, Moreno, V, Diez-Perez, A, Collins, G, Prieto-Alhambra, D

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease by Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis by Alarkawi, D, Bliuc, D, Pallares, N, Tebe, C, Cooper, C, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, K, Diez-Perez, A, Center, J, Prieto-Alhambra, D

Oral bisphosphonates and chronic kidney disease: progression and safety by Prieto-Alhambra, D, Robinson, D, Strauss, V, Ali, S, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, K, Diez-Perez, A

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease by Ali, M, Robinson, D, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Delmestri, A, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis by Robinson, DE, Ali, MS, Pallares, N, Tebé, C, Elhussein, L, Abrahamsen, B, Arden, NK, Ben-Shlomo, Y, Caskey, FJ, Cooper, C, Dedman, D, Delmestri, A, Judge, A, José Pérez-Sáez, M, Pascual, J, Nogues, X, Diez-Perez, A, Strauss, VY, Javaid, MK, Prieto-Alhambra, D

Clinical sub-phenotypes of Staphylococcus aureus bacteraemia by Swets, MC, Bakk, Z, Westgeest, AC, Berry, K, Cooper, G, Sim, W, Lee, RS, Gan, TY, Donlon, W, Besu, A, Heppenstall, E, Tysall, L, Dewar, S, de Boer, M, Fowler, VG, Dockrell, DH, Thwaites, GE, Pujol, M, Pallarès, N, Tebé, C, Carratalà, J, Szubert, A, Groeneveld, GH, Russell, CD